|
 
|
|
|
|
DISEASE: Ovarian
Select a REGIMEN:
AP
DISEASE: Ovarian REGIMEN: AP
Caution: Monitor cumulative dose (cardiac toxicity) CISPLATIN [CDDP] 50 mg/m2 IV...D1
REFER: Bruckner HW, et al: PROC ASCO 1979; 20:414. DISEASE: Ovarian REGIMEN: CC
CYCLOPHOSPHAMIDE [CTX] 600 mg/m2 IV
REFER: Skeel RT: Handbook of Cancer Chemotherapy, 3rd Ed. Little, Brown & Co. 1991; 210. DISEASE: Ovarian REGIMEN: CHAD/IV
ALTRETAMINE [HMM] 150 mg/m2 per day PO...D2-8
DOXORUBICIN [DOX] 30 mg/m2 IV...D1
CISPLATIN [CDDP] 60 mg/m2 IV...D1
REFER: Edmonson JH, et al: CANCER TREAT REP 1985; 69:1243-1248. DISEASE: Ovarian REGIMEN: CHAP
ALTRETAMINE [HMM] 150 mg/m2 per day PO...D2-8
DOXORUBICIN [DOX] 30 mg/m2 IV...D1
CISPLATIN [CDDP] 50 mg/m2 IV...D1
REFER: Bruckner HW, et al: PROC ASCO 1979; 20:414. DISEASE: Ovarian REGIMEN: CP
CISPLATIN [CDDP] 50 mg/m2 IV
REFER: Decker DG, et al: OBSTET GYNECOL 1982; 60:481-487. DISEASE: Ovarian REGIMEN: HEXA-CAF
CYCLOPHOSPHAMIDE [CTX] 150 mg/m2 per day PO...D1-14 METHOTREXATE [MTX] 40 mg/m2 IV...D1,8 FLUOROURACIL [5-FU] 600 mg/m2 IV...D1,8
REFER: Young RC, et al: NEJM 1978; 299:1261-1266. DISEASE: Ovarian REGIMEN: PAC-1
DOXORUBICIN [DOX] 45 mg/m2 IV...D1
CYCLOPHOSPHAMIDE [CTX] 600 mg/m2 IV...D1
REFER: Conte PF, et al: J CLIN ONCOL 1986; 4:965-971. DISEASE: Ovarian REGIMEN: PACLITAXEL
REFER: TAXOL(R) (paclitaxel) Bristol-Myers Squibb Co, prescribing info in PHYSICIANS DESK REFERENCE 49th Ed. Montvale,NJ; 1995;682. |
 Medicine OnLine and UltiTech have no liability for content or goods on the Internet except as set forth in the Terms and Conditions of service. =Please read the Disclaimer of Warranties before using information contained in this section. © Copyright 1995-2009 UltiTech, Inc. All Rights Reserved. |
| [ Top Of Page | Regimens Index | DoseCalc Index ] |
|